AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
5.17
-0.16 (-3.00%)
Jul 10, 2026, 4:00 PM EDT - Market closed
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $1.9 billion as of July 10, 2026. Its market cap has increased by 311.35% in one year.
Market Cap
1.90B
Enterprise Value
1.68B
1-Year Change
311.35%
Ranking
Category
Stock Price
$5.17
Market Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has decreased from $2.29B to $1.90B, a decrease of -16.83%. That is a compound annual growth rate of -3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.90B | 28.13% |
| Dec 31, 2025 | 1.49B | 565.64% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lakefront Biotherapeutics NV | 2.01B |
| Recursion Pharmaceuticals | 2.00B |
| Nanobiotix | 1.98B |
| AnaptysBio | 1.97B |
| Precigen | 1.97B |
| Tyra Biosciences | 1.96B |
| UroGen Pharma | 1.96B |
| Iovance Biotherapeutics | 1.95B |